Please login to the form below

Not currently logged in


This page shows the latest Darzalex news and features for those working in and with pharma, biotech and healthcare.

Sanofi makes ‘best-in-class’ claim for Sarclisa in myeloma

Sanofi makes ‘best-in-class’ claim for Sarclisa in myeloma

Meanwhile, the IV formulation of Darzalex still has the considerable advantage of being well-established in the market and already a cornerstone of multiple myeloma therapy. ... Analysts at Jefferies said recently they don’t think Sarclisa will catch

Latest news

More from news
Approximately 27 fully matching, plus 31 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company
W2O Group

W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....